Veana Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer (NCT04120246) | Veana Therapeutics | 2020-04-08 |
Track Veana Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.